Form 4 for EW Edwards Lifesciences
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-05 · accession 0001225208-24-001597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-05 | 2024-02-05 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $87.49 | -29.4K | 4,486 | -87% | -$2.57M |
| D | 2024-02-05 | 2024-02-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2024-02-05 | 2024-02-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $0.00 | -29.4K | 88.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-05 | S | D | 1,000 | $89.61 | 32,835.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $89.390 to $90.080. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-02-05 | M | A | 29,350 | $36.75 | 33,835.82 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-05 | S | D | 6,422 | $88.63 | 26,413.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $88.210 to $89.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2024-02-05 | S | D | 9,761 | $86.44 | 16,652.82 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $86.100 to $87.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-02-05 | S | D | 12,167 | $87.55 | 4,485.82 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $87.110 to $88.105. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | Employee Stock Option (Right to Acquire) | 2024-02-05 | M | D | 29,350 | $0.00 | 88,050 | D | $36.75 · 2017-06-11 to 2024-05-10 | 29,350 Common Stock |